z-logo
open-access-imgOpen Access
Early Cytokine Removal in Critical COVID-19 Patients with Extracorporeal Therapies (HA-380 plus High Volume Hemofiltration) May Prevent Progression of Acute Respiratory Distress Syndrome: Case Report
Author(s) -
Gonzalo RamírezGuerrero,
Vicente Torres Cifuentes,
Romyna Baghetti Hernández,
Francisco Villagrán Cortés,
Simón Rojas Doll,
Rocio Oliva Alarcón,
Cristian Lucero Córdova,
Pablo Flores Fernandez,
Osvaldo Garay Coloma
Publication year - 2020
Publication title -
blood purification
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 57
eISSN - 1421-9735
pISSN - 0253-5068
DOI - 10.1159/000512982
Subject(s) - medicine , hemofiltration , extracorporeal , pneumonia , covid-19 , acute respiratory distress , cytokine release syndrome , respiratory distress , intensive care medicine , extracorporeal membrane oxygenation , anesthesia , lung , disease , hemodialysis , infectious disease (medical specialty)
We present the case of a patient who suffered from acute respiratory distress syndrome caused by pneumonia associated with COVID-19 and cytokine release syndrome. This patient received a high-volume hemofiltration plus adsorption, solving the hemodynamic deterioration, pulmonary infiltrates, and gas exchange. Our clinical case proposes that the extracorporeal therapies can have a role in the management of severe COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom